Citius Oncology Statistics
NASDAQ: CTORHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.5035-0.0619 (-10.95%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Citius Oncology by the numbers
Citius Oncology has a market capitalization of $53.2 million based on 105.76M shares outstanding. With trailing EPS of $-0.48, Citius Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.2% below its 50-day average and 36.5% below its 200-day average.
Average daily trading volume is 114.02K shares, or about $57,407 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTOR valuation vs. peer median
| Metric | CTOR | Peer median | Difference |
|---|---|---|---|
| Market cap | $53.25M | $52.69M | +1% |
| Avg. volume | 114.02K | 89.91K | +27% |
Peer median across 8 companies: LFVN, XBIT, XLO, ALDX, CLNN, BOLD, AZR, ACRV.
Valuation
- Market cap
- $53.25M
- EPS (TTM)
- $-0.48
- Shares outstanding
- 105.76M
Price and trading
- Previous close
- 0.5654
- Open
- 0.5698
- Day range
- 0.502 – 0.5698
- 52-week range
- 0.491 – 1.83
- 52-week change
- -55.44%
- 50-day moving average
- 0.7542
- 200-day moving average
- 0.7935
- Beta
- —
- Volume
- 52.63K
- Average volume
- 114.02K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 22, 2026
Additional statistics
- Market Cap
- 53.25M
- Eps
- -0.48
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.83
- Week52 Low
- 0.49
- Avg Volume
- 114.02K
- Shares Outstanding
- 105.76M
- Ma50
- 0.75
- Ma200
- 0.79
- Earnings Date
- Dec 22, 2026
- Pct From52w High
- -72.49%
- Pct From52w Low
- 2.55%